WW International (WW, Financial) experienced a significant stock price increase, soaring 20.7% to $1.40. Early trading saw the stock rise as much as 46.5%.
The surge follows the company's announcement to integrate compounded semaglutide, starting at $129, into its weight loss solutions. This addition broadens access for eligible members to clinical weight management interventions, which are grounded in comprehensive and scientifically backed behavioral and lifestyle support.
